{"id":"dibotermin-alfa","rwe":[{"pmid":"34890287","year":"2022","title":"Cost-effectiveness of 4 mg dibotermin alfa/absorbable collagen sponge versus iliac crest bone graft for lumbar degenerative disc disease in the United Kingdom.","finding":"","journal":"Journal of medical economics","studyType":"Clinical Study"},{"pmid":"27441597","year":"2016","title":"Distinct Gene Expression Patterns Defining Human Osteoblasts' Response to BMP2 Treatment: Is the Therapeutic Success All a Matter of Timing?","finding":"","journal":"European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes","studyType":"Clinical Study"},{"pmid":"26359326","year":"2015","title":"Is dibotermin alfa a cost-effective substitute for autologous iliac crest bone graft in single level lumbar interbody spine fusion?","finding":"","journal":"Current medical research and opinion","studyType":"Clinical Study"},{"pmid":"25119632","year":"2014","title":"[New drugs for small animals in 2013].","finding":"","journal":"Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere","studyType":"Clinical Study"},{"pmid":"23549148","year":"2013","title":"The cost-effectiveness of periodic safety update reports for biologicals in Europe.","finding":"","journal":"Clinical pharmacology and therapeutics","studyType":"Clinical Study"}],"tags":[{"label":"Biologic","category":"modality"},{"label":"M05BC01","category":"atc"},{"label":"Active","category":"status"},{"label":"Degeneration of intervertebral disc","category":"indication"},{"label":"Fracture of tibia","category":"indication"},{"label":"Medtronic BioPharma B.V.","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Medtronic BioPharma B.V.","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=DIBOTERMIN ALFA","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:48:30.718807+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:48:35.798579+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-20T03:48:30.787050+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DIBOTERMIN ALFA","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:48:36.003571+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Activin receptor type-2A agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:48:37.220806+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2109171/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:48:36.881656+00:00"}},"allNames":"inductos","offLabel":[],"synonyms":["dibotermin alfa","inductos","rhBMP-2","recombinant human Bone Morphogenetic Protein-2"],"timeline":[{"date":"2002-09-09","type":"positive","source":"DrugCentral","milestone":"EMA approval (Medtronic BioPharma B.V.)"}],"approvals":[{"date":"2002-09-09","orphan":false,"company":"Medtronic BioPharma B.V.","regulator":"EMA"}],"brandName":"Inductos","ecosystem":[{"indication":"Degeneration of intervertebral disc","otherDrugs":[],"globalPrevalence":null},{"indication":"Fracture of tibia","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"modality":"Biologic","explanation":"","oneSentence":"","technicalDetail":"The exact mechanism of action of Inductos is unknown, but it is believed to involve the modulation of specific biological pathways involved in tissue repair and regeneration."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5024","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=DIBOTERMIN%20ALFA","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DIBOTERMIN ALFA","fields":["publications"],"source":"PubMed/NCBI"}],"_emaChecked":true,"_enrichedAt":"2026-03-30T10:38:38.491222","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:48:38.452632+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"dibotermin alfa","indications":{"approved":[{"name":"Degeneration of intervertebral disc","source":"DrugCentral","snomedId":77547008,"regulator":"FDA"},{"name":"Fracture of tibia","source":"DrugCentral","snomedId":31978002,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06904898","phase":"NA","title":"CONDUIT vs. PEEK Cages","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2021-03-13","conditions":["Lumbar Degenerative Disease"],"enrollment":60,"completionDate":"2026-07-31"},{"nctId":"NCT07475416","phase":"NA","title":"Effect of Mandibular Drilling Speed on Implant Stability and Osteogenic Potential: A Randomized Clinical Trial","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-03-15","conditions":["Edentulism","Tooth Loss"],"enrollment":36,"completionDate":"2027-04-01"},{"nctId":"NCT04234971","phase":"PHASE4","title":"Cost Effectiveness in Alveolar Bone Grafting in Patients With Cleft Lip and Palate","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-06-14","conditions":["Cleft Lip and Palate"],"enrollment":40,"completionDate":"2028-01-01"},{"nctId":"NCT04073563","phase":"NA","title":"Transforaminal Lumbar Interbody Fusion (TLIF)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medtronic Spinal and Biologics","startDate":"2019-12-19","conditions":["Degenerative Disease of the Lumbosacral Spine"],"enrollment":600,"completionDate":"2028-07"},{"nctId":"NCT06462729","phase":"PHASE1,PHASE2","title":"LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)","status":"RECRUITING","sponsor":"Locate Bio Pty Ltd","startDate":"2024-11-12","conditions":["Degenerative Disc Disease","Lumbar Disc Disease","Spine Disease","Lumbar Spine Degeneration"],"enrollment":40,"completionDate":"2027-12"},{"nctId":"NCT04670965","phase":"","title":"Release Kinetics of rhBMP-2 Using E-PRF as an Autologous Carrier: An In Vitro Analysis","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04","conditions":["Bone Loss"],"enrollment":20,"completionDate":"2028-07"},{"nctId":"NCT07240493","phase":"NA","title":"BMP Effect on Implant Stability and Marginal Bone Level After Immediate Placement","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aya Adil Saeed","startDate":"2024-12-15","conditions":["Unrestorable Tooth Replaced by Immediate Implant With BMP"],"enrollment":24,"completionDate":"2026-01"},{"nctId":"NCT02924571","phase":"NA","title":"BMAC & Allograft vs BMP-2","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2018-07-24","conditions":["Spinal Fusion"],"enrollment":59,"completionDate":"2024-06-03"},{"nctId":"NCT05238740","phase":"NA","title":"Comparison of Radiographic Fusion Rate and Clinical Outcome of ALIF and XLIF Performed With Either Recombinant Human Bone Morphogenetic Protein-2 or ViviGen®","status":"RECRUITING","sponsor":"Lindenhofgruppe AG","startDate":"2022-10-27","conditions":["Spondylosis","Spondylolisthesis","Degenerative Disc Disease"],"enrollment":168,"completionDate":"2027-12"},{"nctId":"NCT06715345","phase":"NA","title":"Efficacy and Safety of Novosis Putty for Degenerative Lumbar Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"CGBio Inc.","startDate":"2024-03-06","conditions":["Degenerative Lumbar Diseases"],"enrollment":48,"completionDate":"2025-12-31"},{"nctId":"NCT06148441","phase":"","title":"Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2024-01-01","conditions":["In-stent Restenosis"],"enrollment":100,"completionDate":"2025-02"},{"nctId":"NCT05405374","phase":"NA","title":"OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study","status":"UNKNOWN","sponsor":"Bioventus LLC","startDate":"2022-05-06","conditions":["Lumbar Spine Disease","Lumbar Spondylolisthesis","Lumbar Spine Instability","Lumbar Spondylosis","Degenerative Disc Disease"],"enrollment":101,"completionDate":"2025-10"},{"nctId":"NCT05911477","phase":"NA","title":"Recombinant Human Bone Morphogenetic Protein-2(rhBMP-2) in Patients With Osteoporosis After Lumbar Fusion","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2023-07-01","conditions":["Osteoporosis","Spinal Fusion"],"enrollment":76,"completionDate":"2024-06-30"},{"nctId":"NCT01491386","phase":"NA","title":"Pivotal Study of rhBMP-2/ACS/LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease","status":"COMPLETED","sponsor":"Medtronic Spinal and Biologics","startDate":"1998-08","conditions":["Degenerative Disc Disease"],"enrollment":279,"completionDate":"2002-10"},{"nctId":"NCT01491542","phase":"NA","title":"INFUSE® Bone Graft and MASTERGRAFT® Granules With CD HORIZON® for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease - Pilot Study","status":"COMPLETED","sponsor":"Medtronic Spinal and Biologics","startDate":"2003-04","conditions":["Degenerative Disc Disease"],"enrollment":46,"completionDate":"2007-03"},{"nctId":"NCT01491451","phase":"NA","title":"A Pilot Study of rhBMP-2/ACS With the INTERFIX™ Device for the AnteriorLumbar Interbody Fusion in Patients With Degenerative Disc Disease","status":"COMPLETED","sponsor":"Medtronic Spinal and Biologics","startDate":"1999-02","conditions":["Degenerative Disc Disease"],"enrollment":45,"completionDate":"2003-01"},{"nctId":"NCT01494454","phase":"NA","title":"Clinical Study of rhBMP-2/BCP With the TSRH® Spinal System for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease","status":"COMPLETED","sponsor":"Medtronic Spinal and Biologics","startDate":"1999-08","conditions":["Degenerative Disc Disease"],"enrollment":197,"completionDate":"2007-11"},{"nctId":"NCT01494428","phase":"NA","title":"A Pilot Study of rhBMP-2/ACS/Allograft Bone Dowel for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease","status":"COMPLETED","sponsor":"Medtronic Spinal and Biologics","startDate":"1998-04","conditions":["Degenerative Disc Disease"],"enrollment":46,"completionDate":"2004-02"},{"nctId":"NCT01491399","phase":"NA","title":"INFUSE™ BONE GRAFT/CORNERSTONE-SR™ Allograft Ring/ATLANTIS™ Anterior Cervical Plate- Pilot Study","status":"COMPLETED","sponsor":"Medtronic Spinal and Biologics","startDate":"1999-09","conditions":["Degenerative Cervical Disc Disease"],"enrollment":33,"completionDate":"2003-03"},{"nctId":"NCT01494493","phase":"NA","title":"Pivotal Study of rhBMP-2/ACS/Allograft Bone Dowel for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease","status":"TERMINATED","sponsor":"Medtronic Spinal and Biologics","startDate":"2000-09","conditions":["Degenerative Disc Disease"],"enrollment":85,"completionDate":"2004-02"},{"nctId":"NCT01491425","phase":"NA","title":"A Pivotal Study of rhBMP-2/ACS/LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease","status":"COMPLETED","sponsor":"Medtronic Spinal and Biologics","startDate":"1998-11","conditions":["Degenerative Disc Disease"],"enrollment":134,"completionDate":"2002-10"},{"nctId":"NCT01491464","phase":"NA","title":"A Pivotal Study of rhBMP-2/ACS/INTER FIX™ Device for Posterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease","status":"TERMINATED","sponsor":"Medtronic Spinal and Biologics","startDate":"1999-03","conditions":["Degenerative Disc Disease"],"enrollment":67,"completionDate":"2002-09"},{"nctId":"NCT01495234","phase":"NA","title":"Pilot Study of rhBMP-2/BCP in Patients With Spinal Degeneration With Instability Requiring Surgical Fusion","status":"COMPLETED","sponsor":"Medtronic Spinal and Biologics","startDate":"1996-10","conditions":["Degenerative Disc Disease"],"enrollment":15,"completionDate":"2001-06"},{"nctId":"NCT01494441","phase":"NA","title":"Pilot Study of rhBMP/BCP With or Without the TSRH® Spinal System for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease","status":"COMPLETED","sponsor":"Medtronic Spinal and Biologics","startDate":"1999-05","conditions":["Degenerative Disc Disease"],"enrollment":27,"completionDate":"2003-03"},{"nctId":"NCT01491568","phase":"NA","title":"rhBMP-2/CRM/CD HORIZON® Spinal System Pilot Study (2-Level)","status":"COMPLETED","sponsor":"Medtronic Spinal and Biologics","startDate":"2005-07","conditions":["Degenerative Disc Disease"],"enrollment":29,"completionDate":"2010-11"},{"nctId":"NCT05065684","phase":"","title":"Effect of rhBMP-2 or rhBMP-7 on Long Bone Fractures and Non-unions.","status":"COMPLETED","sponsor":"University Hospital Muenster","startDate":"2005-01","conditions":["Long Bone Non-union"],"enrollment":150,"completionDate":"2012-01"},{"nctId":"NCT00707265","phase":"PHASE3","title":"rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study","status":"COMPLETED","sponsor":"Medtronic Spinal and Biologics","startDate":"2002-03","conditions":["Degenerative Disc Disease"],"enrollment":463,"completionDate":"2010-02"},{"nctId":"NCT05717478","phase":"NA","title":"Regeneration of Alveolar Sockets With rhBMP-2-loaded Bovine Bone Mineral","status":"UNKNOWN","sponsor":"Universidad Complutense de Madrid","startDate":"2022-11-15","conditions":["Loss of Teeth Due to Extraction","Alveolar Bone Loss","Edentulous Alveolar Ridge"],"enrollment":40,"completionDate":"2024-09-15"},{"nctId":"NCT05719181","phase":"PHASE1","title":"Effect of Recombinant Human Bone Morphogenetic Protein-2 With an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study.","status":"UNKNOWN","sponsor":"University of Baghdad","startDate":"2021-12-06","conditions":["Hypertension","Diabetes Mellitus","Blood Disease"],"enrollment":32,"completionDate":"2023-04-20"},{"nctId":"NCT00856479","phase":"PHASE4","title":"A Randomized Controlled Cost Study of Infuse BMP 2 vs Iliac Crest Autograft for Non Union of Long Bone Fractures","status":"WITHDRAWN","sponsor":"Ross Leighton","startDate":"2009-03","conditions":["Non Union Diaphyseal Fractures"],"enrollment":0,"completionDate":"2013-03"},{"nctId":"NCT05555420","phase":"NA","title":"BMP-2 and ALP Levels Following Laser Therapy With Scaling and Root Planing in Periodontitis- RCT.","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2022-11-01","conditions":["Periodontitis, Laser"],"enrollment":20,"completionDate":"2023-12-01"},{"nctId":"NCT05369091","phase":"PHASE4","title":"Salivary Bmp-2 Levels & Radiographic Measurement Of Bone Density at Extracted Tooth","status":"COMPLETED","sponsor":"Postgraduate Medical Institute, Lahore","startDate":"2020-12-16","conditions":["Bone Injury"],"enrollment":24,"completionDate":"2022-01-05"},{"nctId":"NCT01541345","phase":"PHASE3","title":"Lateral Ridge Augmentation Using Autogenous Bone Blocks or Xenogenic Bone Block Grafts Loaded With Recombinant Human Bone Morphogenic Protein 2","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2011-02","conditions":["Missing Teeth"],"enrollment":24,"completionDate":"2019-06-04"},{"nctId":"NCT04489251","phase":"","title":"Assessment of the TGF-beta Pathway and Micro-RNA in Pediatric Pulmonary Arterial Hypertension","status":"UNKNOWN","sponsor":"Medical College of Wisconsin","startDate":"2020-07-01","conditions":["Pulmonary Arterial Hypertension"],"enrollment":40,"completionDate":"2023-01-01"},{"nctId":"NCT02718131","phase":"NA","title":"A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)","status":"TERMINATED","sponsor":"University of Alabama at Birmingham","startDate":"2016-03-01","conditions":["NF1","Congenital Pseudarthrosis of Tibia"],"enrollment":5,"completionDate":"2020-06-01"},{"nctId":"NCT05025306","phase":"PHASE3","title":"Healing Effect of Ziziphus Honey on Extracted Tooth Socket in Humans by Evaluating the Levels of BMP-2 and OPN","status":"COMPLETED","sponsor":"Postgraduate Medical Institute, Lahore","startDate":"2020-01-01","conditions":["Healing Wound"],"enrollment":30,"completionDate":"2020-06-01"},{"nctId":"NCT04566874","phase":"NA","title":"SPIRA™-A 3D and HCT/p DBM vs. Medtronic Divergent™-L/Perimeter™ and Recombinant BMP-2","status":"UNKNOWN","sponsor":"Camber Spine Technologies","startDate":"2020-07-13","conditions":["Degenerative Disc Disease","Spinal Stenosis","Spondylolisthesis","Scoliosis"],"enrollment":100,"completionDate":"2021-07"},{"nctId":"NCT04372420","phase":"NA","title":"Bone Morphogenetic Protein-2 In Grade II Furcation Defects.","status":"COMPLETED","sponsor":"SVS Institute of Dental Sciences","startDate":"2017-12-05","conditions":["Periodontitis"],"enrollment":44,"completionDate":"2019-10-10"},{"nctId":"NCT04368650","phase":"PHASE2","title":"RhBMP-2 in Intrabony Defects - A Randomized Controlled Trial","status":"COMPLETED","sponsor":"SVS Institute of Dental Sciences","startDate":"2017-12-05","conditions":["Periodontitis"],"enrollment":40,"completionDate":"2019-10-11"},{"nctId":"NCT00752557","phase":"PHASE2","title":"Study Evaluating Changes In Bone Mineral Density (BMD), And Safety Of Rhbmp-2/CPM In Subjects With Decreased BMD","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-12-03","conditions":["Osteoporosis"],"enrollment":50,"completionDate":"2015-04-24"},{"nctId":"NCT04140006","phase":"PHASE1,PHASE2","title":"Efficacy of Antiresorptive and Bone Forming Material on Dental Implants","status":"UNKNOWN","sponsor":"University of Baghdad","startDate":"2019-07-01","conditions":["Partial Edentulism"],"enrollment":20,"completionDate":"2020-07-01"},{"nctId":"NCT03527966","phase":"PHASE4","title":"rhBMP-2 Versus Vivigen in Lumbar Fusion Procedures","status":"TERMINATED","sponsor":"Virtua Health, Inc.","startDate":"2017-07-03","conditions":["Lumbar Spine Degeneration"],"enrollment":3,"completionDate":"2018-07-27"},{"nctId":"NCT03769402","phase":"PHASE4","title":"The Influence of Citric Acid Bone Surface Etching and Bone Defect Fill on GCF BMP-2 Release Profile","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2016-01-01","conditions":["Intrabony Periodontal Defect"],"enrollment":20,"completionDate":"2018-11-01"},{"nctId":"NCT00853489","phase":"PHASE4","title":"rhBMP-2 Versus Autograft in Critical Size Tibial Defects","status":"TERMINATED","sponsor":"St. Louis University","startDate":"2011-08","conditions":["Tibial Fractures"],"enrollment":33,"completionDate":"2017-02-17"},{"nctId":"NCT02178605","phase":"","title":"rhBMP-2 in Cervical Arthrodesis","status":"COMPLETED","sponsor":"Virginia Spine Institute","startDate":"2008-10","conditions":["Cervical Arthrodesis"],"enrollment":300,"completionDate":"2017-12"},{"nctId":"NCT01308996","phase":"NA","title":"Clinical Study of INFUSE® Bone Graft Compared to Autogenous Bone Graft for Vertical Ridge Augmentation","status":"WITHDRAWN","sponsor":"Medtronic Spinal and Biologics","startDate":"2012-04","conditions":["Alveolar Bone Loss in Mandible","Edentulous Alveolar Ridge In Mandible"],"enrollment":0,"completionDate":"2017-09"},{"nctId":"NCT01430299","phase":"NA","title":"Efficacy and Safety of Accell Evo3 Demineralized Bone Matrix (DBM) in Instrumented Posterolateral Lumbar Spine Fusion","status":"COMPLETED","sponsor":"SeaSpine, Inc.","startDate":"2011-06","conditions":["Stenosis","Spondylosis","Degenerative Changes"],"enrollment":43,"completionDate":"2016-10"},{"nctId":"NCT02714829","phase":"NA","title":"Clinical Study of Injectable Ceramics Bone Graft Substitute Containing rhBMP-2","status":"COMPLETED","sponsor":"BioAlpha Inc.","startDate":"2016-04","conditions":["Alveolar Bone Preservation","Bone Graft"],"enrollment":88,"completionDate":"2018-04"},{"nctId":"NCT03396900","phase":"PHASE2","title":"Periodontally Accelerated Osteogenic Orthodontics With BMP2","status":"COMPLETED","sponsor":"SVS Institute of Dental Sciences","startDate":"2016-07-01","conditions":["Malocclusion"],"enrollment":30,"completionDate":"2017-11-01"},{"nctId":"NCT01690260","phase":"PHASE1","title":"Parallel Study Between BMP-2 and Autologous Bone Graft After Ilizarow Treatment","status":"COMPLETED","sponsor":"Northern Orthopaedic Division, Denmark","startDate":"2004-09","conditions":["Bone Degenerative Changes","Osteoarthritis","Degenerative Disorder of Bone"],"enrollment":41,"completionDate":"2017-10-02"},{"nctId":"NCT01013389","phase":"NA","title":"Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion (PLIF) With Interbody Fusion","status":"COMPLETED","sponsor":"Baxter Healthcare Corporation","startDate":"2007-06","conditions":["Degenerative Disc Disease"],"enrollment":20,"completionDate":"2012-12"},{"nctId":"NCT01018771","phase":"NA","title":"Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion","status":"COMPLETED","sponsor":"Baxter Healthcare Corporation","startDate":"2009-07","conditions":["Degenerative Disc Disease"],"enrollment":100,"completionDate":"2012-12"},{"nctId":"NCT02280187","phase":"","title":"InductOs® in Real World Spine Surgery; A Retrospective, French, Multi-centric, Study","status":"COMPLETED","sponsor":"Medtronic Spinal and Biologics","startDate":"2014-10","conditions":["Spine Fusion"],"enrollment":400,"completionDate":"2015-10"},{"nctId":"NCT00829621","phase":"NA","title":"Incisional Vacuum Assisted Closure (IVAC) Device and Its Effect on Implanted Bone Morphogenic Protein (BMP-2)","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2008-12","conditions":["Fractures, Closed"],"enrollment":20,"completionDate":"2013-12"},{"nctId":"NCT00422279","phase":"NA","title":"A Study of Dental Implants Coated With Bone Morphogenetic Protein","status":"COMPLETED","sponsor":"Nobel Biocare","startDate":"2006-11","conditions":["Alveolar Ridge Abnormality"],"enrollment":4,"completionDate":"2009-11"},{"nctId":"NCT02735538","phase":"","title":"Transcription Factor Runx2 in Necrotic Femoral Head Tissue","status":"COMPLETED","sponsor":"Shengjing Hospital","startDate":"2009-07","conditions":["Osteonecrosis of Femoral Head"],"enrollment":30,"completionDate":"2011-12"},{"nctId":"NCT01415908","phase":"PHASE3","title":"INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine","status":"TERMINATED","sponsor":"Medtronic Spinal and Biologics","startDate":"2011-07","conditions":["Lumbar Spine Degeneration"],"enrollment":15,"completionDate":"2015-01"},{"nctId":"NCT02609074","phase":"PHASE4","title":"Pilot Clinical Trial of CPC/rhBMP-2 Microffolds as Bone Substitute for Bone Regeneration","status":"COMPLETED","sponsor":"East China University of Science and Technology","startDate":"2013-03","conditions":["Bone Fracture"],"enrollment":81,"completionDate":"2015-10"},{"nctId":"NCT02504242","phase":"PHASE3","title":"A Multi-center, Comparative Clinical Trial to Evaluate the Efficacy and Safety of Inject BMP in Patients Undergoing Transforaminal Lumbar Interbody Fusion","status":"UNKNOWN","sponsor":"BioAlpha Inc.","startDate":"2015-04","conditions":["Transforaminal Lumbar Interbody Fusion"],"enrollment":128,"completionDate":""},{"nctId":"NCT01756144","phase":"NA","title":"rhBMP-2 vs Autologous Bone Grafting for the Treatment of Non-union of the Docking Site in Tibial Bone Transport","status":"UNKNOWN","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2015-07","conditions":["Pseudarthrosis"],"enrollment":20,"completionDate":"2016-04"},{"nctId":"NCT01764906","phase":"NA","title":"The Clinical Study of Novosis in Posterolateral Fusion","status":"UNKNOWN","sponsor":"BioAlpha Inc.","startDate":"2013-03","conditions":["Posterolateral Fusion"],"enrollment":90,"completionDate":"2016-03"},{"nctId":"NCT01016067","phase":"PHASE3","title":"Tibial Delayed Healing Pivotal Clinical Trial","status":"TERMINATED","sponsor":"Medtronic Spinal and Biologics","startDate":"2010-11","conditions":["Tibial Delayed Healing"],"enrollment":23,"completionDate":"2013-12"},{"nctId":"NCT01958502","phase":"PHASE2","title":"Evaluation the Treatment of Nonunion of Long Bone Fracture of Lower Extremities (Femur and Tibia) Using Mononuclear Stem Cells From the Iliac Wing Within a 3-D Tissue Engineered Scaffold","status":"UNKNOWN","sponsor":"Emdadi Kamyab Hospital","startDate":"2013-07","conditions":["Nonunion of Fracture"],"enrollment":18,"completionDate":"2014-11"},{"nctId":"NCT01491477","phase":"NA","title":"INFUSE ® Bone Graft/CORNERSTONE-SR® Allograft Ring/ATLANTIS® Anterior Cervical Plate System Pivotal Trial","status":"TERMINATED","sponsor":"Medtronic Spinal and Biologics","startDate":"2002-04","conditions":["Degenerative Cervical Disc Disease"],"enrollment":3,"completionDate":"2005-04"},{"nctId":"NCT01491373","phase":"NA","title":"Pilot Study of rhBMP-2/ACS/LT-CAGE® for Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease","status":"COMPLETED","sponsor":"Medtronic Spinal and Biologics","startDate":"1997-01","conditions":["Degeneration of Lumbar Intervertebral Disc"],"enrollment":14,"completionDate":"1999-09"},{"nctId":"NCT00384852","phase":"PHASE2","title":"A Study of rhBMP-2/CPM in Closed Fractures of the Humerus","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2007-01","conditions":["Fractures"],"enrollment":139,"completionDate":"2010-02"},{"nctId":"NCT00384358","phase":"PHASE2","title":"Feasibility And Safety Study Of rhBMP-2/CPM For Hip Fractures","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2006-12","conditions":["Fractures"],"enrollment":108,"completionDate":"2010-06"},{"nctId":"NCT00387686","phase":"PHASE2,PHASE3","title":"A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures","status":"TERMINATED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2006-11","conditions":["Fractures"],"enrollment":367,"completionDate":"2010-03"},{"nctId":"NCT00405600","phase":"NA","title":"Spine Fusion Instrumented With BMP-2 vs Uninstrumented With Infuse BMP-2 Alone","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2006-11","conditions":["Degenerative Lumbar Disc Disease","Spondylolisthesis","Spinal Stenosis"],"enrollment":50,"completionDate":"2010-12"},{"nctId":"NCT01725698","phase":"PHASE1","title":"The Combined Effect of Mesenchymal Stem Cell, HA-CaSO4,BMP-2, and Implant in Inducing The Healing of Critical-Sized Bone Defect","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2012-11","conditions":["Union"],"enrollment":5,"completionDate":"2014-12"},{"nctId":"NCT01634308","phase":"PHASE3","title":"Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2010-06","conditions":["Regeneration of Alveolar Tissue After Maxillary Sinus Floor Augmentation"],"enrollment":0,"completionDate":"2012-06"},{"nctId":"NCT00161616","phase":"PHASE4","title":"Study Evaluating InductOs in Diaphyseal Tibia Fractures","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2003-09","conditions":["Tibial Fractures"],"enrollment":277,"completionDate":"2008-08"},{"nctId":"NCT00161629","phase":"PHASE1","title":"Study Evaluating rhBMP-2/CPM in Closed Distal Radius Fractures","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-09","conditions":["Radius Fractures"],"enrollment":40,"completionDate":"2007-01"},{"nctId":"NCT00243295","phase":"PHASE1","title":"Study Evaluating rhMBP-2/CPM in Open Wedge Osteotomies","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2003-11","conditions":["Osteoarthritis"],"enrollment":6,"completionDate":"2005-03"}],"_emaApprovals":[{"date":"2002-09-09","status":"Authorised","company":"Medtronic BioPharma B.V."}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"011701","UNII":"T472P45MG6","INN_ID":"8107","UMLSCUI":"C1445578","chemblId":"CHEMBL2109171","ChEMBL_ID":"CHEMBL2109171","DRUGBANK_ID":"DB11639","SNOMEDCT_US":"408090006","MESH_SUPPLEMENTAL_RECORD_UI":"C499469"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Medtronic BioPharma B.V.","relationship":"Original Developer"}],"publicationCount":7,"therapeuticAreas":["Bone"],"atcClassification":{"source":"DrugCentral","atcCode":"M05BC01","allCodes":["M05BC01"]},"biosimilarFilings":[],"originalDeveloper":"Medtronic BioPharma B.V.","recentPublications":[{"date":"2022 Jan-Dec","pmid":"34890287","title":"Cost-effectiveness of 4 mg dibotermin alfa/absorbable collagen sponge versus iliac crest bone graft for lumbar degenerative disc disease in the United Kingdom.","journal":"Journal of medical economics"},{"date":"2016","pmid":"27441597","title":"Distinct Gene Expression Patterns Defining Human Osteoblasts' Response to BMP2 Treatment: Is the Therapeutic Success All a Matter of Timing?","journal":"European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes"},{"date":"2015 Nov","pmid":"26359326","title":"Is dibotermin alfa a cost-effective substitute for autologous iliac crest bone graft in single level lumbar interbody spine fusion?","journal":"Current medical research and opinion"},{"date":"2014","pmid":"25119632","title":"[New drugs for small animals in 2013].","journal":"Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere"},{"date":"2013 May","pmid":"23549148","title":"The cost-effectiveness of periodic safety update reports for biologicals in Europe.","journal":"Clinical pharmacology and therapeutics"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"Medtronic BioPharma B.V.","companyId":"medtronic-biopharma-b-v","modality":"Recombinant protein","firstApprovalDate":"2002","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:48:38.452632+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}